Although current clinical studies directly addressing these mechanisms are limited, our findings underscore the need for future studies to simultaneously measure PA, cysteamine, pantetheine, and vanin-1 to provide a more comprehensive understanding of this complex pathway in the context of diabetes and its cardiovascular complications. Here, VNN1 is linked to diabetes mellitus.